Carlos Cruz

Thoracic Surgeon

[Yakup Ergün @dr_yakupergun]

Lung Cancer-Subtypes

IHC panel👇

[Jordi Remon @JordiRemon]

Treatment landscape of early-stage NSCLC is evolving very fast. We review current SoC with IO and targeted therapies(TT) and future challenges:
-Neoadj vs periop?
-IO in borderline resectable
-How to ⬆️pCR
-Role of TT..
@peters_solange @g_mountzios
https://t.co/d7DXBbYkXI

[jpedrokessner @KessnerJp]

Pulmonary Nodules: an excellent review!
🫁🩻🚬🎞⏳️🐍⚖️⚔️🎯
https://t.co/V1uhZwqY9c
@NEJM @pneumosbpt @ALATorax @NeumoMadrid @Neumosur @separrespira @socap @ers @ats

[CHEST @accpchest]

Original research indicates that Composite Allocation Score (CAS) implementation has increased lung transplantation rates and decreased waitlist time with no meaningful differences in primary and secondary outcomes between the eras.

Read more in #journal_CHESTCritCare: https://t.co/vhvadiO13r
#MedEd #JournalCHEST #CriticalCare #CritCare #LungTransplant

[CardiovascularCorner @TrackYourHeart]

Pulmonary Infection on CT: From Pattern Recognition to Pathogen

[José Manuel Porcel Pérez @JoseMPorcel]

Revisiting Light's criteria: a validated blood-free triple combination matches diagnostic accuracy in over 7000 patients https://t.co/CPuVw1UlMl

[Sociedad de Medicina de Emergencias de la Laguna @SOMELaguna]

🫁🦠Manejo Local de la Infección Pleural

🔰📚European Journal of Medical Research 2026

https://t.co/6JBtM8fvXD

Enlace a Artículo Completo✅👇🏻🆓
https://t.co/rPEDXf5xvO

[CHEST® Journal @journal_CHEST]

A CHEST Special Features article explores the past, present, and future of intrapleural fibrinolytic therapy.

Read more in the February issue of the journal CHEST®: https://t.co/HgGNt46FKs
#MedEd #JournalCHEST

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

Las #neumonias🫁pueden complicarse: #DerramePleuralComplicado o #Empiema🟢y los #AntibioticosSistemicos NO son suficientes💊❌.En #EurJMedRes REVISIÓN🙇🏻‍♂️ sobre CUANDO⏳y COMO 🔪💉utilizar tratamientos #locales (drenaje, suero, ATB, cirugía…)
🔗🆓 https://t.co/pBbsnOcZr3

[JHLT @TheJHLT]

In a randomized clinical trial of conventional vs open lung protective ventilator strategy (#OLPVS) in deceased US organ donors, OLPVS was found to be safe but did not improve donor lung utilization or oxygenation compared to a conventional strategy.

🔗: https://t.co/rSAIOeucAS

[CHEST @accpchest]

The latest CHEST How I Do It article outlines best practices for right heart catheterization in the diagnosis of #PulmonaryHypertension.

Read the article in the September issue of the journal CHEST®: https://t.co/HkznOHTdI0
#MedEd #JournalCHEST #PH

[AATS @AATSHQ]

Open Access in #JTCVS: Outcomes of reoperation following prior vascular ring and airway compression surgery from researchers at @BostonChildrens. The study shows promising results for reoperative vascular ring surgery. Read for free: https://t.co/87It9ElEwL

[Leonardo Santos @Leo_Santo5]

Infecciones en Cavidad Pleural 🫁🦠

🔰📚Life 2023

https://t.co/FnLlvJtWME

Enlace a Artículo Completo 👇🏼✅🆓https://t.co/xumUMHaxVK

[ECMO Barcelona @ECMOHUVH]

https://t.co/FM2C4vcYrm
En este link hay información esencial para cualquier #ECMO Center.
Asistencia ECMO de calidad: contenido de #ECMOBARNA2025, en primeras dos semanas de noviembre. Un curso con certificado @ELSOOrg
Últimas plazas disponibles para presencial!

[Ahmed Ata @Ahmedata7777]

Why anticoagulation in DVT, PE and Antiplatelets in myocardial infarction!!

Red thrombus vs White thrombus!

1. DVT (Deep Vein Thrombosis)

》Pathophysiology: DVT occurs in the venous system, where stasis of blood, hypercoagulability, and endothelial injury (Virchow's triad) lead to clot formation.

》Clot Composition: Venous thrombi are fibrin-rich and contain lots of red blood cells and fewer platelets. These are sometimes called "red clots."

》Treatment Rationale: Since the clot is largely fibrin-based, anticoagulants like heparin, warfarin, or DOACs (e.g., apixaban, rivaroxaban) are effective—they target the coagulation cascade and prevent fibrin formation.

2. Myocardial Infarction (MI)

》Pathophysiology: MI is often due to rupture of an atherosclerotic plaque in a coronary artery, which triggers platelet activation and aggregation.

》Clot Composition: Arterial thrombi are platelet-rich, also called "white clots," formed under high shear stress.

》Treatment Rationale: Antiplatelet agents like aspirin (inhibits COX-1, reducing thromboxane A2) and P2Y12 inhibitors (e.g., clopidogrel, ticagrelor) are key to prevent platelet aggregation and subsequent occlusion of the coronary artery.

[PHAEUROPE @EuropePHA]

💙 goodPHnews – Croatia’s First Balloon Pulmonary Angioplasty
On August 10, 2025, KBC Split achieved a milestone—Croatia’s first balloon pulmonary angioplasty (BPA) for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Led by Dr. Mislav Lozo...⤵️

[Mauricio Danckers, MD, MEHP, FCCP @DanckersMD]

Kicked off Day 1 of our Bronch Primer Workshop . An amazing time with my fellows — full of learning 📚 and fun 🎉!

[TransplantDirect @TXPDirect]

Scarcity of size-matched donor lungs limits pediatric & small adult lung transplants. Study reports 4 consecutive cases of split heterotopic bilateral lobar Lung Tx—maximizing donor lung use & expanding options for this high-need group. #TXPforAll https://t.co/rZ8LJEpeBt

[jpedrokessner @KessnerJp]

Sedation in bronchoscopy: an excellent review.
https://t.co/03iZmwF2mD
🫁🐍💉😶‍🌫️🥱😌😁
@ERSpublications @EuroRespSoc @BTSrespiratory @SPLF_SocPneumo @young_dgp @SeparRespira @ALATorax @NeumoMadrid @neumoparatodos @HUReinaSofia @NeumologiaHR @RespirologyAPSR @ACCP @journal_CHEST

[ERS publications @ERSpublications]

ERJ Open Research: Bronchoscopic lung volume reduction using one-way endobronchial valves is effective in reducing the clinically relevant symptoms of fatigue, anxiety and depression in COPD patients with advanced emphysema and static hyperinflation https://t.co/76psLEEuIi